Why Most Health-tech Products Fail In India Despite Strong Clinical Value

By Author: Binu Bhasursan
Total Articles: 1
Comment this article

Most health-tech products in India do not fail because the technology is weak. They fail because the healthcare system they are trying to enter is far more complex than the software itself.

That system is human, layered, political, and often invisible to outsiders building solutions from the outside in.

And this is something I did not fully understand early enough.

The Illusion of Rational Decision-Making

When health-tech companies first approach hospitals, everything appears structured and process-driven.

There are meetings, product demonstrations, committees, approvals, and follow-up discussions. The entire process creates the impression that decisions are made logically — based on efficiency, outcomes, and clinical value.

But beneath that formal structure lies a very different reality.

In many Indian hospitals:

Decisions are rarely fully democratic
Authority does not always align with job titles
Verbal agreement does not necessarily lead to implementation

You may leave a meeting believing approval has been secured, only to discover weeks later that ...
... nothing has actually progressed.

What sounded like a “yes” in conversation was never truly a “yes” in authority.

Authority Is Often Invisible

One of the biggest mistakes in health-tech sales is assuming that authority belongs to whoever holds the highest designation.

If someone is a department head, administrator, or senior clinician, they are often assumed to be the final decision-maker. But hospitals rarely operate through formal hierarchies alone.

A senior consultant who never attended your demo may still influence the final outcome more than everyone in the room.

A department head may publicly support the idea but quietly resist implementation.

An administrator may genuinely like the product but lack the influence required to push adoption forward.

And sometimes, the actual decision-maker is not visible at all.

This is where many health-tech products fail to understand the system they are entering.

They optimize for the visible layer — the presentations, meetings, and approval workflows — while completely missing the invisible network of influence that truly governs adoption.

In healthcare systems, influence often matters more than designation.

If founders fail to recognize this early, they do not lose because the product lacks value. They lose because they were never communicating with the real system in the first place.

Why “Yes” Rarely Means Adoption

Positive feedback can be one of the most misleading signals in healthcare innovation.

In many hospital environments, direct rejection is often avoided because saying “no” can feel socially uncomfortable or professionally sensitive. So instead, organisations offer soft approval — responses that keep conversations alive without committing to actual change.

For founders, this becomes dangerous.

It creates the illusion of momentum without any real movement.

You continue investing time, expanding discussions, preparing future plans, and assuming implementation is progressing — even when no real commitment exists.

I have personally seen situations where there was strong clinical support, successful pilot outcomes, and clear operational value, yet nothing moved forward.

That experience revealed an important reality:

A system that improves outcomes can still fail if it disrupts informal workflows, challenges existing hierarchies, or exposes inefficiencies people have quietly adapted to.

Alignment Is the Real Challenge

In India, conversations around healthcare innovation often focus heavily on affordability and accessibility. While these are important challenges, they are not the only reasons adoption fails.

Even the most affordable and clinically effective solution will struggle if it does not align with:

Institutional priorities — what the hospital actually values
Power structures — who benefits from the change
Cultural dynamics — how decisions are truly made and delayed
Workflow realities — how work actually happens beyond official processes

Without this alignment, even an excellent product becomes an external system attempting to enter a closed environment.

If you do not understand who truly influences adoption, then you are not really selling into the hospital system — you are simply presenting to it.

And presentations alone do not create transformation.

Successful implementation requires alignment across multiple invisible layers of authority, trust, workflow, and institutional behavior.

Without that alignment, products often remain stuck in a permanent state of “under consideration.”

The Real Lesson About Healthcare Innovation

One of the biggest lessons from working around Indian healthcare systems is this:

Successful health-tech products cannot be built by optimizing only for clinical outcomes.

They must also optimize for organisational absorption.

Because even the best technology will struggle if the system itself is not ready, willing, or structurally aligned to adopt it.

So perhaps the real challenge in healthcare innovation is not simply building better technology.

It is understanding the invisible systems that determine whether change is accepted at all.

What are your thoughts on this?